Neto Malinda Trading Ltd. (TLV:NTML)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions ILS. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,814	1,603	964	1,729	2,187	1,263
Market Cap Growth	97.94%	66.32%	-44.27%	-20.91%	73.09%	19.91%
Enterprise Value	3,033	1,748	1,484	2,220	2,103	1,330
Last Close Price	142.20	78.83	45.96	82.48	104.29	60.25
PE Ratio	12.36	7.85	10.92	13.53	11.40	8.64
PS Ratio	0.57	0.33	0.22	0.41	0.62	0.39
PB Ratio	1.85	1.10	0.75	1.45	2.06	1.29
P/TBV Ratio	1.89	1.12	0.77	1.48	2.10	1.33
P/FCF Ratio	19.23	5.67	6.60	-	33.34	10.82
P/OCF Ratio	14.99	4.94	4.52	-	25.56	9.51
EV/Sales Ratio	0.61	0.36	0.34	0.53	0.59	0.41
EV/EBITDA Ratio	8.97	5.98	9.07	10.22	7.32	5.66
EV/EBIT Ratio	10.53	6.89	11.37	12.40	8.34	6.61
EV/FCF Ratio	20.73	6.18	10.16	-	32.06	11.39
Debt / Equity Ratio	0.16	0.07	0.24	0.37	0.23	0.04
Debt / EBITDA Ratio	0.72	0.32	1.73	2.05	0.84	0.17
Debt / FCF Ratio	1.65	0.35	2.08	-	3.68	0.35
Asset Turnover	2.29	2.40	2.28	2.32	2.32	2.52
Inventory Turnover	7.39	8.19	8.00	7.95	7.41	8.49
Quick Ratio	1.87	2.12	1.88	1.70	1.58	2.25
Current Ratio	2.78	3.12	2.83	2.52	2.40	3.33
Return on Equity (ROE)	16.46%	15.32%	7.29%	11.69%	21.35%	19.46%
Return on Assets (ROA)	8.25%	7.95%	4.25%	6.19%	10.29%	9.83%
Return on Capital (ROIC)	10.46%	10.10%	5.04%	7.59%	13.58%	13.22%
Return on Capital Employed (ROCE)	17.90%	16.60%	9.60%	13.90%	22.90%	20.10%
Earnings Yield	8.09%	12.73%	9.16%	7.39%	8.77%	11.57%
FCF Yield	5.20%	17.64%	15.15%	-6.79%	3.00%	9.24%
Payout Ratio	49.96%	23.22%	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.